Skip to main content
Premium Trial:

Request an Annual Quote

Evotec Inks Screening Pact with Active Biotech

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Evotec said today that it will use its high-throughput compound screening and assay development technologies to identify small molecule modulators for a target selected by Stockholm-based Active Biotech.

Under the agreement, Evotec will use its high-throughput and surface plasmon resonance screens with its Lead Discovery Library to identify and validate novel hits that will complement ongoing Active Biotech studies of a target that may be involved immune disorders and cancer.

Evotec has developed assays and high-throughput screens for a range of target classes, including GPCRs, kinases and other enzymes, and ion channel and protein interactions.

Financial terms of the agreement were not released.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.